Recent work in mice has identified AMP‐dependent regulation of fructose‐1,6‐bisphosphatase 1 (FBP1) as a critical indirect anti‐hyperglycaemic target of the most widely used diabetes drug metformin [12]. The gene discussed is FBP1; the disease is diabetes mellitus.